Last Updated on December 16, 2019 by Inspire Malibu It’s true, Millennials – people around the ages of 22 to 38 years old – are changing up the alcohol consumption game. This news, while positive and a move in the right direction, still comes with a dose of reality. Alcohol remains the third leading cause […]
Last Updated on June 16, 2021 by Inspire Malibu In March 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Spravato (Esketamine) for use in patients diagnosed with treatment-resistant depression. Spravato is a nasal spray that can only be administered by an approved health care provider, in the physician’s office or clinic, […]
Last Updated on September 4, 2019 by Inspire Malibu “Magic Mushrooms,” an organic species of hallucinogenic-fungi containing psilocybin as the main psychoactive ingredient, are making headway into mainstream medical research. In late 2018 The Food and Drug Administration (FDA) granted “breakthrough therapy” designation to a study into psilocybin therapy for treatment-resistant depression (TRD). “Psilocybin may […]
Last Updated on December 16, 2019 by Inspire Malibu Before psychedelic drugs like psilocybin mushrooms, peyote, mescaline and LSD were outlawed in the United States, scientists studied the potential medicinal effects of these substances with great interest. After the Controlled Substances Act of 1970 classified a number of psychedelics as Schedule I narcotics, funding for […]
